logo
Nkosana Makate ‘still resilient' as ConCourt overturns billion-rand ruling in battle with Vodacom

Nkosana Makate ‘still resilient' as ConCourt overturns billion-rand ruling in battle with Vodacom

Daily Maverick5 days ago
In a scathing judgment, Acting Deputy Chief Justice Mbuyiseli Madlanga described the nearly 20-year legal battle between Nkosana Makate and Vodacom as 'unending litigation' and slammed the Supreme Court of Appeal for multiple errors in its February 2024 ruling, which would have awarded Makate billions for his Please Call Me idea.
When Nkosana Makate walked into the corridors of the Constitutional Court on Thursday, 31 July, where Justice Mbuyiseli Madlanga was set to deliver his final ruling from the bench, he was in high spirits, hopeful that the court would finally bring an end to his battle with telecommunications giant Vodacom, a fight that had gone on for almost 20 years.
Hours later, the court delivered another blow for Makate as it unanimously referred the matter back to the Supreme Court of Appeal (SCA) and instructed that a new panel of judges reconsider the case.
Delivering a scathing judgment, Madlanga described the almost two-decade legal saga as an unending litigation and said the SCA made several errors in its February 2024 judgment, which would have seen Makate net at least R9-billion. That ruling has now been set aside.
'The Supreme Court of Appeal failed to provide adequate reasons for its judgment and disregarded or was unaware of certain material acts and issues before it,' Madlanga said.
WATCH | The Constitutional Court has unanimously ruled in favour of Vodacom, setting aside the 2024 SCA decision that ordered the company to pay Nkosana Makate between 5% and 7.5% of the revenue earned from the service over 18 years. The matter will now return to the SCA. pic.twitter.com/04dTUBZpNz
— Nonkululeko Njilo (@Nkulee_Njilo) July 31, 2025
The SCA had ruled that Makate was entitled to be paid 5% to 7.5% of the total revenue of the Please Call Me (PCM) product from March 2001 to the date of judgment, plus interest. This Constitutional Court had previously ordered Vodacom to pay him 'reasonable' compensation, which led Vodacom to offer R47-million.
The R9-billion determined by the Supreme Court of Appeal would have 'devastating consequences' for the mobile-network operator, its employees and its investors, Johannesburg-based Vodacom said in its papers.
'Forever resilient'
Speaking to journalists after the judgment, Makate said: 'We expected a different decision but we have to abide by the court's decision. We will go to the SCA and it must just relook at the case and provide us with a judgment that will then stand the test.'
Asked whether he felt disappointed by the legal system – after years of back-and-forth in his dispute with Vodacom over compensation for the call-back service idea he presented to the company's product development team while working in its finance division in the 2000s – Makate said:
'I think they could have finalised the matter. We still had a hearing at the high court which they could have gone to as well and then ignored the SCA completely.'
Makate said he remained resilient and was confident that justice would ultimately be served: 'I am still resilient, I will forever be.'
While the case has proven to be financially and emotionally costly, Makate said he would explore all avenues available to him.
'We will do what we have to do,' he said.
It was the second time the case was heard by the ConCourt. In 2016, the court affirmed that Makate was the inventor of Please Call Me and ordered Vodacom to enter into good-faith negotiations with him to determine reasonable compensation.
However, compensation talks between Makate and Vodacom have been acrimonious as he accused the company of deliberately withholding information about the lucrativeness of Please Call Me.
In 2020, the High Court in Pretoria made a similar ruling as it ordered Vodacom to play open cards and disclose financial records relating to the Please Call Me service, including the revenue it has generated for the telecommunications giant.
This was considered a victory for Makate, who used the financial records to determine the settlement that Vodacom could shell out for his idea that gave rise to the service. DM
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UK grants space launch licence to Scottish firm
UK grants space launch licence to Scottish firm

TimesLIVE

timean hour ago

  • TimesLIVE

UK grants space launch licence to Scottish firm

Britain has granted its first space launch licence to a home-grown rocket company, paving the way for a Scottish start-up to send satellites into space from the country's first vertical launch spaceport. Skyrora, founded in 2017, would be able to conduct up to 16 launches a year, subject to further approval by the UK Civil Aviation Authority (CAA), the regulator said on Tuesday. The Scotland-based company would use the SaxaVord Spaceport in the Shetland Islands, northern Scotland, which received a key safety licence last year, meaning rockets could be launched from the site in the future. Germany's Rocket Factory Augsburg was the first company to gain a licence to launch from the site earlier this year. 'Granting a home-grown company, Skyrora, its launch licence is a major milestone for our space sector and our nation,' CAA CEO Rob Bishton said. The space market is forecast to be worth more than $1-trillion (R18.04-trillion) by 2030 as companies around the world plan to deploy thousands of internet-beaming satellites. Britain has been looking to add launch capabilities to its space industry, which employs more than 45,000 people and builds more satellites than anywhere outside the US. But those efforts were dealt a major blow in early 2023 when a horizontal rocket launch from Newquay, southwest England, failed. A successful vertical launch from SaxaVord would revive the industry's prospects. 'Skyrora is proud to be leading efforts that enable launch activity from the UK and we look forward to achieving a reliable commercial launch programme that benefits us all,' CEO Volodymyr Levykin said. The company needs to meet a number of conditions before any launch, including adequate insurance, a data-sharing deal with the British government and airspace agreements with other countries.

Sibanye-Stillwater's call for US tariff on Russian palladium may add to price volatility
Sibanye-Stillwater's call for US tariff on Russian palladium may add to price volatility

TimesLIVE

timean hour ago

  • TimesLIVE

Sibanye-Stillwater's call for US tariff on Russian palladium may add to price volatility

Sibanye-Stillwater has asked the US to consider imposing a tariff on Russian palladium imports to support the long-term viability of US supplies in a move that could increase volatility in palladium prices. The petition filed by Johannesburg-based Sibanye-Stillwater adds another layer of uncertainty to prospects for platinum group metals (PGMs) after a rally in prices this year due to lower first-half production in South Africa and thin liquidity in the spot market. "We believe Russian palladium imports are being sold below market prices due to different factors, beginning primarily after the Russian invasion of Ukraine in 2022," Sibanye-Stillwater CEO Neal Froneman said in a statement on the company's website dated July 31. "Obtaining relief from dumped and subsidised Russian imports will give Sibanye-Stillwater, its employees and the entire US PGM industry an opportunity to compete on a more level playing field." A final decision on the petition is likely within 13 months. Russia's Nornickel, the world's largest palladium producer with a 40% share of global mined output, declined to comment.

Africa's first cell and gene therapy startup raises R29 million in landmark funding round
Africa's first cell and gene therapy startup raises R29 million in landmark funding round

IOL News

time2 hours ago

  • IOL News

Africa's first cell and gene therapy startup raises R29 million in landmark funding round

Altera Biosciences, Africa's first dedicated cell and gene therapy startup, has secured R29 million in one of the largest pre-seed funding rounds in South African biotech history. The Cape Town-based company, co-founded by Alexandra Miszewski and Professor Michael Pepper, is developing a universal donor cell platform aimed at revolutionising transplant medicine and advancing treatments for conditions such as diabetes and cancer. The investment round was led by OneBio Venture Studio and E Squared Investments. 'This investment signals a new era for biotech in Africa,' said Pepper, who is the Director of the Institute for Cellular and Molecular Medicine at the University of Pretoria. 'Africa is the most genetically diverse continent in the world, making it a relevant setting in which to develop advanced therapies.' Miszewski explained that one of the biggest challenges in transplantation medicine is to find a suitable donor-recipient match to prevent rejection of the transplant. 'Rejection occurs when the recipient's immune system recognises the donor's cells as being foreign and mounts an immune response against the transplanted cells.' She explained that Altera is developing 'a universal donor cell platform using gene silencing technology to remove the identity markers on the donor cells that trigger immune rejection.' This, she said, will allow the recipient's body 'to accept the cells as their own, and the problem of rejection is minimised.' Miszewski, an entrepreneur with a background in medical device and biotech startups such as Equine Tendon, Regenesis Vet, and Novita Biotechnology, is a graduate of the Allan Gray Orbis Foundation Fellowship Entrepreneurial Programme. Pepper, who was recently named one of South Africa's top Biology and Biochemistry Scientists, said the universal donor cell platform could allow for off-the-shelf cell therapies suited for genetically diverse populations. 'Many advanced therapies have been developed with a one-size-fits-all approach, which may not be appropriate in a genetically diverse population. By building solutions from a globally diverse genetic foundation, our research has the potential to be more universally applicable from day one,' he said. While Altera has not disclosed which therapeutic areas it will pursue first due to strategic and intellectual property considerations, the company emphasised its commitment to making these technologies accessible in Africa. 'Our vision is global,' said Pepper, 'but we are deeply committed to ensuring these innovations are also accessible to patients in Africa, where access to advanced healthcare is often limited.' The success of the funding round marks a significant milestone for the continent's biotechnology sector, reflecting growing confidence in Africa's potential to contribute to global healthcare innovation. THE MERCURY

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store